Australian Cannabis Biotech Developing Cancer and Epilepsy Drugs

Analysis originally distributed on August 23, 2016 By: Michael Vodicka of Cannabis Stock Trades

MGC Pharmaceuticals (TSX:MXC, OTC:MGCLF) is a young cannabis biotech headquartered in Western Australia that specializes in pharmaceutical product research and development.

MGC

Australian cannabis stocks have been red hot for the last few months.

  • I added Australian-based Cann Group (ASX:CAN) to the members portfolio on July 31 and we're already up 70% in less than three weeks.
  • I added fellow Australian cannabis stock AusCann (OTC:ACNNF) to the member portfolio on June 6 and we're up 55%.

If you want to learn more about our member portfolio click here.

Although the company is incorporated and headquartered in Australia it also has operations in both Israel and Europe.

For example, MGC received two licenses from the Slovenian government to grow, process and trade Cannabis Sativa L (Hemp) and its products, including Cannabidoil (CBD) resin, in Europe.

The company's founders were leaders in Israel's growing medical cannabis industry. Continue reading "Australian Cannabis Biotech Developing Cancer and Epilepsy Drugs"

Cann Group Up 81% In 3 Weeks

Analysis originally distributed on August 16, 2017 By: Michael Vodicka of Cannabis Stock Trades

This week, I want to share AusCann Group Holdings Ltd. (NASDAQ:ACNNF)/ Cann Group (ASX:CAN) with the free newsletter crowd.

This is a stock I rolled out to members two weeks ago as one of our most recent trades. Members will always get the first look at the best ideas and information we have to offer at CST.

Since being added to the CST portfolio, Cann Group has been surging - Cannabis Stock Trades members are up around 75% on this trade.

2nd Australian Cannabis Permit Holder up 99% in 15 Days - More to Come?

Medical cannabis became legal in Australia in November of 2016.

Under the new program, companies interested in entering the industry must apply for and receive a permit from federal regulators to grow and sell cannabis. Continue reading "Cann Group Up 81% In 3 Weeks"

This Cannabis Innovator Is Down 50% In Two Months - Time to Buy?

Analysis originally distributed on August 9, 2017 By: Michael Vodicka of Cannabis Stock Trades

A new and innovative business model is emerging in Canada’s cannabis industry. Not only is it a potentially safer way to invest in the highly volatile cannabis sector, it could also be more profitable than investing in individual cannabis companies.

No, it’s not an ETF or a mutual fund. It’s something called streaming – let me explain.

Cannabis Wheaton Income Corp.(CDNX:CBW) is a young Canadian cannabis company headquartered in Vancouver that just went public in early May.

CBW is pioneering a new and innovative business model in Canada’s cannabis industry known as streaming.

CBW

Streaming means providing funding to cannabis companies to help them build and expand operations in exchange for an equity stake and a portion of the cultivation production.

This model comes straight from the gold and silver mining industry. In fact, Cannabis Wheaton is actually named after Wheaton Precious Metals Corp. (NYSE:WPM), now called Wheaton Precious Metals Corp., a pioneer of streaming in Canada’s precious metals industry. Continue reading "This Cannabis Innovator Is Down 50% In Two Months - Time to Buy?"

Cannabis Cancer Stock Up 207% In 2017

Analysis originally distributed on July 19, 2017 By: Michael Vodicka of Cannabis Stock Trades

Cannabis is a proven treatment for cancer patients struggling with the side effects of chemotherapy such as nausea and loss of appetite.

But now, pre clinical research is showing that cannabis could actually be a cancer killer.

A group of scientists recently reported that THC and CBD slowed the growth and even killed certain cancer cells – including breast, brain and liver cancer – when grown in a lab.

Animal studies also suggest that cannabis could be a cancer killer.

A study conducted by Complutense University, one of the oldest and largest universities in Europe located in Madrid, showed that an injection of a synthetic THC eliminated malignant brain tumors in 1/3 of the rats studied while extending the life of another 1/3. Continue reading "Cannabis Cancer Stock Up 207% In 2017"

More To Come For This Cannabis Lighting Company?

Analysis originally distributed on July 13, 2017 By: Michael Vodicka of Cannabis Stock Trades

There are millions of square feet of cannabis cultivation facilities being built all across North America.

Take Americann (OTC:ACAN) for example. Americann is a U.S. based cannabis company headquartered in Massachusetts. Americann is in the early stages of building a 1 million square foot cultivation facility in Mass that will potentially serve as the primary cultivation hub to supply a huge portion of the Eastern cannabis market.

Cronos Group (CDNX:MJN.V) is another good example. Cronos is a Canadian cannabis company headquartered in Toronto. In May, Cronos announced that one of the companies it owns, Peace, had broke ground on a 315,000 square foot cultivation facility.

This project will include a 286,000 square foot production facility, a 28,000 square foot greenhouse, and a 1,200 square foot extraction laboratory.

When finished, this facility is expected to be one of the largest indoor cannabis production facility in the world.

As you can see, cannabis companies are in the process of hugely ramping up their cultivation capacities to meet the tidal wave of demand for cannabis coming down the pike.

One way to profit is to simply invest in the companies building these cultivation facilities. That could turn out to be extremely profitable.

However, I have an even better way to potentially profit. Continue reading "More To Come For This Cannabis Lighting Company?"